publication venue for
- Harms in Systematic Reviews Paper 2: Methods used to assess harms are neglected in systematic reviews of gabapentin 2022
- Harms in Systematic Reviews Paper 3: Given the same data sources, systematic reviews of gabapentin have different results for harms 2022
- A structured methodology review showed analyses of functional outcomes are frequently limited to “survivors only” in trials enrolling patients at high risk of death 2021